Chelsea winger Mykhailo Mudryk appeals a four-year Football Association doping ban to the Court of Arbitration for Sport after receiving the maximum available suspension
Chelsea FC winger Mykhailo Mudryk has filed an appeal with the Court of Arbitration for Sport (CAS) — the Swiss-based international tribunal that serves as the highest court of appeal in global sport — after the Football Association (FA) handed him a four-year ban, the maximum penalty available under anti-doping rules, following a failed drugs test. The appeal was filed on 25 February 2026 and confirmed by a CAS spokesperson. Mudryk's case has been one of the longest-running doping investigations in recent English football, with the initial positive test predating the suspension by a substantial period. The four-year ban — the maximum sanction under the World Anti-Doping Agency (WADA) Code, which the FA has adopted — suggests the FA found no mitigating circumstances sufficient to warrant a reduction from the standard maximum. Athletes who can demonstrate that a prohibited substance entered their system without fault or negligence on their part can receive reduced or even no sanction under the WADA Code's no fault provisions. For commercial lawyers, the case is of interest beyond its sporting context: Mudryk was signed by Chelsea for a reported fee of approximately £89 million in January 2023, making him one of the Premier League's most expensive imports. A sustained ban would trigger complex questions around his employment contract — including whether Chelsea can terminate or suspend his wages — and potentially give rise to insurance claims and cross-border enforcement issues given his Ukrainian nationality and the involvement of CAS as an arbitral tribunal seated in Lausanne.
Why this matters
The Mudryk case sits at the intersection of sports law, employment law, and international arbitration. CAS proceedings are conducted as arbitration under the CAS Code, with the seat in Lausanne and Swiss law governing the arbitral process — meaning any challenge to a CAS award would be heard by the Swiss Federal Tribunal. For Chelsea, the commercial stakes extend beyond the playing field: a four-year ban on an £89 million asset triggers questions about contractual force majeure provisions, image rights agreements, and whether the club's insurance policies cover wage costs during a ban. The WADA Code's burden of proof rules — which place the initial burden on the anti-doping organisation to establish a rule violation, then shift to the athlete to establish fault mitigation — are the central legal battleground at CAS.
On the Ground
On a sports arbitration matter at CAS, a trainee would assist with disclosure review and categorisation of evidential materials, prepare chronology bundles tracking the timeline of the doping investigation and procedural steps, and assist with court filing and service of the appeal documentation.
Interview prep
Soundbite
An £89 million player serving a four-year ban exposes Chelsea to contract termination disputes, insurance claims, and CAS arbitration simultaneously.
Question you might get
“How does the WADA Code's burden of proof framework work in a doping case, and what would Mudryk need to demonstrate at CAS to achieve a reduction in his four-year ban?”
Full answer
Chelsea's Mykhailo Mudryk has received a four-year FA doping ban — the maximum under the WADA Code — and has appealed to the Court of Arbitration for Sport in Lausanne. The legal significance extends well beyond the sporting outcome: a sustained ban on a player acquired for around £89 million raises immediate questions about Chelsea's ability to suspend or terminate his contract and recover costs through insurance. CAS operates as an arbitral tribunal under the CAS Code, seated in Switzerland, which means any further challenge would go to the Swiss Federal Tribunal — a cross-border enforcement dimension that international arbitration practices at City firms would handle. The WADA Code's no-fault provisions give Mudryk his best legal route to a reduced ban, and the outcome will hinge on evidence about the substance's origin and route of entry.
My notes
saved